Clindamycin Dosage for an 11-Year-Old Child
For an 11-year-old child, clindamycin should be dosed at 30-40 mg/kg/day divided into 3-4 doses, with the specific dosing depending on infection severity and type.
Dosing by Infection Severity and Route
Oral Clindamycin
- Serious infections: 30-40 mg/kg/day divided into 3-4 doses 1
- More severe infections: Up to 40 mg/kg/day divided into 3-4 doses 2
- Maximum: Do not exceed adult doses 3
Intravenous Clindamycin
- Serious infections: 25-40 mg/kg/day divided into 3 doses 4
- More severe infections: 40 mg/kg/day divided into 3-4 doses (every 6-8 hours) 3, 2
Pathogen-Specific Dosing
Since an 11-year-old falls into the <12 years age category, here are the specific recommendations:
For Staphylococcal Infections (including MRSA)
- IV clindamycin: 40 mg/kg/day divided every 6-8 hours 2
- Oral clindamycin: 30-40 mg/kg/day divided into 3-4 doses 2, 4
For Group A Streptococcus
- Oral clindamycin: 40 mg/kg/day divided into 3 doses 2
For Pneumococcal Infections
- Oral clindamycin: 30-40 mg/kg/day divided into 3 doses 3
Practical Dosing Considerations
The 30 mg/kg/day vs 40 mg/kg/day debate: Recent evidence suggests that 30 mg/kg/day may be adequate for many musculoskeletal infections in children, even in MRSA-prevalent communities 5. However, for severe infections, life-threatening infections, or confirmed MRSA, use 40 mg/kg/day 3, 2.
Key Clinical Pearls:
- Dose based on total body weight, regardless of obesity 1
- Capsules must be taken with a full glass of water to avoid esophageal irritation 1
- If the child cannot swallow capsules, use clindamycin palmitate oral solution 1
- Duration: Typically 10 days minimum; β-hemolytic streptococcal infections require at least 10 days 1
- MRSA infections may require longer treatment courses than pneumococcal infections 3
Important Caveats
Watch for diarrhea: Clindamycin carries a risk of Clostridioides difficile infection. If significant diarrhea develops, discontinue the medication immediately 1.
Local resistance patterns matter: The choice between clindamycin and other antibiotics should be guided by local susceptibility data, particularly for MRSA where inducible resistance to clindamycin can occur in erythromycin-resistant strains 4.
Drug interactions: If rifampicin is co-administered, clindamycin clearance increases 3-fold and bioavailability drops dramatically (especially with oral administration), requiring much higher IV doses (≥3600-4800 mg/day in adults) 6. This combination should generally avoid oral clindamycin.